Xenith, LLC (“Xenith”) announced today the launch of the Xenith Shadow, the game’s most advanced football helmet. Xenith Shadow offers athletes the protection, fit, feel and comfort to be the most confident on the field at an approachable price point.
Rigorously engineered and tested for the athlete, the Xenith Shadow is an evolution of the company’s current patented helmet technology. Its streamlined design improves fit and protection while increasing comfort and minimizing distractions. Combining an enhanced shock arrangement with an industry-first, novel polymer shell, it absorbs energy and protects the athlete from a variety of impacts on the field.
To view the multimedia release go to:
https://www.multivu.com/players/English/8460351-xenith-shadow-football-helmet/
Global specialty plastics provider Eastman demonstrates the dominant performance of next-generation material Eastman MXF221 copolyester as a disinfectant-ready polymer for safer healthcare environments at the Medical Design & Manufacturing (MD&M) West trade show in Anaheim, California, Feb. 6 to 8. The latest advancement in biocompatible medical-grade polymers for medical device housings and hardware, Eastman MXF221 offers unsurpassed chemical compatibility with stringent disinfectants used to combat healthcare-associated infections (HAIs) as well as improved durability and impact strength.
To view the multimedia release go to:
https://www.multivu.com/players/English/8261151-eastman-disinfectant-ready-polymer-mdm-west/
Medical, health, technology, healthcare, treatment, Richard Fechter, interview, trade show, MultiVu 8261151
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
Kraton Performance Polymers, Inc. (NYSE: “KRA”), a leading global producer of styrenic block copolymers and other engineered polymers will present a paper and exhibit at Techtextil, June 11-13 in Frankfurt, Germany highlighting NEXAR™ polymer coatings. Kraton will be located in Hall 3.1 booth number J33. Dr. Richard Blackwell, Senior Scientist with Kraton Polymers will host a technical presentation entitled “New Selectively Sulfonated Pentablock Copolymer Imparts Cooling Comfort to Textiles and Nonwovens.” The presentation is scheduled for Wednesday, June 12th at 12:20 pm – 12:45 pm.
To view Multimedia News Release, go to http://www.multivu.com/mnr/45712-kraton-techtextil-frankfurt-2013-nexar-cooling-technology
Merillat brings kitchen innovation to life with the introduction of the new CoreGuard™ Sink Base. Now available, the CoreGuard™ Sink Base is a smart solution that will help keep cabinetry dry and clean for years to come. It’s just one example of the many smart solutions Merillat has developed for today’s kitchens.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/merillat/45822/
